{"database": "lobbying", "table": "lobbying_activities", "rows": [[794333, "31753018-5dcf-4e63-8003-561f638953f8", "Q2", "TEVA PHARMACEUTICALS USA, INC.", 76695, "TEVA PHARMACEUTICALS USA INC", 2009, "second_quarter", "PHA", "S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to \"doughnut hole\" impact; and FDA implementation of the Food & Drug Administration Amendments Act (\"FDAAA\").", "Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)", null, 840000, 0, 0, "2009-07-16T16:48:42-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["794333"], "units": {}, "query_ms": 15.269799041561782, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}